View live COHERUS BIOSCIENCES INC chart to track its stock's price action. Find market predictions, CHRS financials and market news. Coherus BioSciences Inc. [CHRS] Stock trading around $13 ... Previously, the target price had yet another raise from $28 to $29, while H.C. Wainwright kept a Buy rating on CHRS stock. The Average True Range (ATR) for Coherus BioSciences Inc. is set at 1.56, with the Price to Sales ratio for CHRS stock in the period of the last 12 months amounting to 2.92. What is the Forecast Price for Coherus Biosciences Inc ... Wall Street is positive on Coherus Biosciences Inc (CHRS). On average, analysts give Coherus Biosciences Inc a Strong Buy rating. The average price target is $30.714, which means analysts expect the stock to rise by 60.72% over the next twelve months.
7 analysts have issued 1 year price targets for Coherus Biosciences' stock. Their forecasts range from $27.00 to $43.00. On average, they expect Coherus
CHRS Coherus Biosciences (CHRS) — Stock Price and ... Apr 03, 2020 · Real-time trade and investing ideas on Coherus Biosciences (CHRS) CHRS from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. CHRS - Coherus BioSciences Inc Stock quote - CNNMoney.com Find real-time CHRS - Coherus BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business. CHRS - Coherus BioSciences Inc Stock quote - CNNMoney.com Markets Coherus BioSciences, Inc. (CHRS) Stock Price, Quote ... Find the latest Coherus BioSciences, Inc. (CHRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Coherus Biosciences, Inc. - CHRS - Stock Price Today - Zacks
Coherus BioSciences, Inc. - TheStreet - Stock Market
Prev Close 15.95, 52 Wk Low 10.86. Open 16.50, 52 Wk High 23.91. Day Low 15.94, Volume 1.3M. Day High 16.63, Avg 10D Vol 1.1M 5 Feb 2020 Analysts Offer Insights on Healthcare Companies: Coherus Biosciences 3 analysts just weighed in on Coherus Biosciences (CHRS – Research Report), also maintained a Buy rating on the stock with a $43.00 price target. 8 Jul 2019 JPMorgan analysts are defending sliding CHRS stock "strong buy" recommendations, and the average 12-month price target is up at $29.50. Key Stats. 1.75 mean rating - 8 analysts. Sell. Hold. Buy BRIEF-Coherus Prices Public Offering Of Common Stock. * SAYS PUBLIC OFFERING OF 5.17 20 Feb 2020 Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CHRS shares is $32.57 per 5 Feb 2020 The analyst keeps a Buy rating on Coherus Biosciences with a $43 price target. CHRS Coherus Biosciences. $19.47 /. +0.75 (+4.01%).
BidaskClub Upgrades Coherus Biosciences (NASDAQ:CHRS) to ...
Find the latest Coherus BioSciences, Inc. (CHRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Coherus Biosciences, Inc. - CHRS - Stock Price Today - Zacks
Coherus BioSciences Analysts: This is the Analysts-site for the company Coherus BioSciences on Markets Insider
14 Apr 2019 How Price Targets are Determined. A price target is an analyst's or trader's expectation of the future price of an asset, such as a stock, futures 20 Nov 2019 Home Depot stock fell 5.4% on Tuesday after posting lower-than-expected Q3 sales. Some analysts cut their price targets following its lower Coherus Biosciences (CHRS). CHRS 16.12 0.17 (1.07%). NASDAQUpdated Apr 7, 2020 9:17 PM. 1,552. Watchers. Watch. Filter by: Real-Time Coherus Biosciences stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.